Trial Outcomes & Findings for Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy (NCT NCT02882633)
NCT ID: NCT02882633
Last Updated: 2019-06-11
Results Overview
Change in pain scores, as measured by the Visual Analog Scale (0-10). 10 is worst imaginable pain and 0 means no pain at all.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
50 participants
Primary outcome timeframe
Change from baseline through 15 minutes
Results posted on
2019-06-11
Participant Flow
Participant milestones
| Measure |
Lumbar Plexus Block
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
Fascia Iliac Block
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
|---|---|---|
|
Overall Study
STARTED
|
25
|
25
|
|
Overall Study
COMPLETED
|
23
|
25
|
|
Overall Study
NOT COMPLETED
|
2
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Lumbar Plexus Block
n=23 Participants
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
Fascia Iliaca Block
n=25 Participants
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
Total
n=48 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
38.83 years
STANDARD_DEVIATION 11.55 • n=23 Participants
|
39.8 years
STANDARD_DEVIATION 11.40 • n=25 Participants
|
39.34 years
STANDARD_DEVIATION 11.36 • n=48 Participants
|
|
Sex: Female, Male
Female
|
16 Participants
n=23 Participants
|
16 Participants
n=25 Participants
|
32 Participants
n=48 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=23 Participants
|
9 Participants
n=25 Participants
|
16 Participants
n=48 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Body Mass Index
|
29.89 kg/m^2
STANDARD_DEVIATION 6.59 • n=23 Participants
|
26.80 kg/m^2
STANDARD_DEVIATION 4.52 • n=25 Participants
|
28.28 kg/m^2
STANDARD_DEVIATION 5.76 • n=48 Participants
|
|
Femoral/Acetabular osteoplasty
|
19 Participants
n=23 Participants
|
23 Participants
n=25 Participants
|
42 Participants
n=48 Participants
|
|
Peri-trochanteric space surgery
|
4 Participants
n=23 Participants
|
2 Participants
n=25 Participants
|
6 Participants
n=48 Participants
|
PRIMARY outcome
Timeframe: Change from baseline through 15 minutesChange in pain scores, as measured by the Visual Analog Scale (0-10). 10 is worst imaginable pain and 0 means no pain at all.
Outcome measures
| Measure |
Lumbar Plexus Block
n=23 Participants
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
Fascia Iliac Block
n=25 Participants
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
|---|---|---|
|
Pain Score Change
|
3 change in score on a scale
Interval 1.0 to 3.0
|
1.72 change in score on a scale
Interval 0.0 to 8.0
|
PRIMARY outcome
Timeframe: While in PACU. An average length of stay for Lumbar Plexus Block group was 165.04 min and 139.72 min for Fascia Iliaca Block group.Participants need for pain relief as measured by opiate consumption
Outcome measures
| Measure |
Lumbar Plexus Block
n=23 Participants
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
Fascia Iliac Block
n=25 Participants
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
|---|---|---|
|
Amount of Opiate Consumption
|
16.98 mg
Interval 5.81 to 22.5
|
20.80 mg
Interval 5.62 to 33.75
|
SECONDARY outcome
Timeframe: Change from baseline through 24 hoursScore of QoR survey to determine recovery status. 0-18 where 0 is the worst and 18 is the best feeling.
Outcome measures
| Measure |
Lumbar Plexus Block
n=23 Participants
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
Fascia Iliac Block
n=25 Participants
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
|---|---|---|
|
Quality of Recovery
|
14.52 Score on a scale
Interval 14.0 to 17.0
|
15.91 Score on a scale
Interval 11.0 to 18.0
|
Adverse Events
Lumbar Plexus Block
Serious events: 1 serious events
Other events: 1 other events
Deaths: 0 deaths
Fascia Iliac Block
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Lumbar Plexus Block
n=23 participants at risk
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
Fascia Iliac Block
n=25 participants at risk
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
|---|---|---|
|
Surgical and medical procedures
Epidural Spread
|
4.3%
1/23 • Number of events 1 • Adverse Effects data collected day of procedure and following 48 hours
|
0.00%
0/25 • Adverse Effects data collected day of procedure and following 48 hours
|
Other adverse events
| Measure |
Lumbar Plexus Block
n=23 participants at risk
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
Fascia Iliac Block
n=25 participants at risk
Subjects will receive single shot local anesthetic, 30 ml bolus of bupivacaine, given preoperatively to help with postoperative pain
30ml bolus of bupivacaine: Local anesthetic
|
|---|---|---|
|
Surgical and medical procedures
Epidural Spread
|
4.3%
1/23 • Number of events 1 • Adverse Effects data collected day of procedure and following 48 hours
|
0.00%
0/25 • Adverse Effects data collected day of procedure and following 48 hours
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place